Last reviewed · How we verify
NCT05058274: HIPER-AT-TORBI
Clinical Results of a Monofocal Aspheric Bitoric Intraocular Lens With Plate Haptics in Hyperopic Eyes (HIPER-AT-TORBI)
trial testing Implant of the AT-TORBI 709 lens in Astigmatism in 60 participants. Completed in 21 February 2024.
21 February 2024
Quick facts
| Lead sponsor | OFTALVIST (Oftalmología Vistahermosa S.L) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 3 November 2021 |
| Primary completion | 21 February 2024 |
| Estimated completion | 21 February 2024 |
| Sites | 2 locations across Spain |
Drugs / interventions tested
- Implant of the AT-TORBI 709 lens
Conditions studied
- Astigmatism — all drugs for Astigmatism →
- Far Sightedness — all drugs for Far Sightedness →
- Cataracts — all drugs for Cataracts →
Sponsor
OFTALVIST (Oftalmología Vistahermosa S.L)
Who can join
50 and older, any sex, with Astigmatism or Far Sightedness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Observational post-marketing study with prospective follow-up of CE marked medical devices aimed at the treatment of hyperopia and astigmatism in patients with cataract. The objective is to evaluate the clinical results of the implantation of the monofocal aspheric bitoric intraocular lens (IOL) with AT-TORBI 709 plate haptics in cataract surgery of hyperopic eyes with astigmatism.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Results of a Monofocal Aspheric Bitoric Intraocular Lens with Plate Haptics in Hyperopic Eyes.
Tañá-Rivero P, Muñoz-Tomás JJ, Orts-Vila P, Artiaga-Elordi E, et al · · 2024 · PMID 38983598 · DOI 10.2147/opth.s467523
Verify or expand the search:
- PubMed search for NCT05058274
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Astigmatism
Currently open trials in the same condition.
- NCT07303920 — Wear Experience With Daily Disposable Contact Lenses for Astigmatism Over a Long-Wear Day · NA · recruiting
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
- NCT07084844 — Patient Reported Outcomes With WaveLight Plus LASIK · recruiting
- NCT07140653 — Arcuate Incisions With Light Adjustable Lens for Astigmatism Correction in Lens Surgery · Phase 4 · recruiting
Other OFTALVIST (Oftalmología Vistahermosa S.L) trials
Trials by the same sponsor.
- NCT05239715 — Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract · completed
- NCT05053620 — Astigmatism Correction With Intrastromal Arcuate Incisions in Eyes Undergoing Cataract Surgery With Femtosecond Laser Us · completed
- NCT04875247 — IOLMASTER 700 Central Topography Workflow Study. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05058274 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by OFTALVIST (Oftalmología Vistahermosa S.L)
- Last refreshed: 22 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05058274.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing